M G Phipps
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
M G Phipps has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
J F Peipert
2 shared publications- David B. Seifer
Yale School of Medicine, New Haven, USA
1 shared publication - Geralyn Lambert-Messerlian
Department of Pathology and Laboratory Medicine Women and Infants Hospital and the Alpert Medical School at Brown University Providence Rhode Island USA
1 shared publication J A Canick
1 shared publication- Joseph W. Hogan
Department of Biostatistics, Brown University School of Public Health, Providence, RI
1 shared publication
Latest Publications
- 1 February 2000
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 95 (2) , 227-231
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies
To determine whether a combination of serum and urine biomarkers drawn from symptomatic pregnant women will help early differentiation of viable from nonviable pregnancies. We conducted a prospective cohort study of 220 women who presented in the first trimester of pregnancy with complaints of pain, cramping, bleeding, or spotting. Serum samples for progesterone, inhibin A, and hCG, and urine beta-core hCG, were collected at presentation. To evaluate whether those biomarkers could predict viable and nonviable outcomes in pregnancy, we used likelihood ratios to compare operating characteristics of single and multiple biomarker strategies. Of 220 pregnancies studied, 98 were viable and 122 nonviable. Among single biomarkers, progesterone alone appears to have the greatest utility (area under the receiver operator characteristic curve = 0.923). Among dual-biomarker strategies, progesterone plus hCG and progesterone plus inhibin A improved specificity but not sensitivity. At 95% sensitivity, the combination of progesterone and hCG improved specificity from 0.29 to 0.66 (improvement = 0.37 [95% confidence interval 0.23, 0.52]). A triple-biomarker combination did not show substantial improvement over the dual-biomarker strategy. Also, combinations that used urine beta-core hCG did not improve diagnostic accuracy. Serum progesterone appeared to be the single most specific biomarker for distinguishing viable from nonviable pregnancies. When a dual-biomarker strategy was applied, combining serum progesterone with hCG, specificity improved significantly, which suggests that a multiple biomarker strategy might help distinguish viable from nonviable pregnancies in early gestation.
- 1 February 2000
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 95 (2) , 227-231
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies
To determine whether a combination of serum and urine biomarkers drawn from symptomatic pregnant women will help early differentiation of viable from nonviable pregnancies. We conducted a prospective cohort study of 220 women who presented in the first trimester of pregnancy with complaints of pain, cramping, bleeding, or spotting. Serum samples for progesterone, inhibin A, and hCG, and urine beta-core hCG, were collected at presentation. To evaluate whether those biomarkers could predict viable and nonviable outcomes in pregnancy, we used likelihood ratios to compare operating characteristics of single and multiple biomarker strategies. Of 220 pregnancies studied, 98 were viable and 122 nonviable. Among single biomarkers, progesterone alone appears to have the greatest utility (area under the receiver operator characteristic curve = 0.923). Among dual-biomarker strategies, progesterone plus hCG and progesterone plus inhibin A improved specificity but not sensitivity. At 95% sensitivity, the combination of progesterone and hCG improved specificity from 0.29 to 0.66 (improvement = 0.37 [95% confidence interval 0.23, 0.52]). A triple-biomarker combination did not show substantial improvement over the dual-biomarker strategy. Also, combinations that used urine beta-core hCG did not improve diagnostic accuracy. Serum progesterone appeared to be the single most specific biomarker for distinguishing viable from nonviable pregnancies. When a dual-biomarker strategy was applied, combining serum progesterone with hCG, specificity improved significantly, which suggests that a multiple biomarker strategy might help distinguish viable from nonviable pregnancies in early gestation.
- 1 October 1997
- Vol. 80 (10) , 321-5
Pelvic inflammatory disease in Rhode Island: epidemiology, diagnosis and therapy.
- 1 October 1997
- Vol. 80 (10) , 321-5
Pelvic inflammatory disease in Rhode Island: epidemiology, diagnosis and therapy.